5 Questions Posed By Britain’s Slowing Vaccination Rates

The UK’s Covid vaccine uptake rate has slowed down to a snail’s pace in the past two months.

While 88% of the population has received at least one vaccine jab according to the government’s figures from September 4, this is only a slight increase from July 1, when 82% had received a single dose.

So what does this mean for the UK’s vaccine rollout?

1. Who is not getting vaccinated?

While data shows the 16-17 year olds are currently the least vaccinated group, this age bracket was only advised to get the jab by the government in August.

The onus actually lies with a slightly older age group.

Of those aged 18-24, 65% have received their first dose, while for those aged 25-29, 63% have had one jab and 68% of 30-39-year-olds.

This means the overall vaccination rate among 18-40-year-olds has barely changed since July – approximately a third of individuals in this age bracket have not received their first dose.

The vaccination rates among those aged 50 and up have also flatlined, but the uptake among these individuals for their first jab has been above 80% for some months. The 40-49-year-old bracket is only just behind as well, with 79% of the group having received at least one dose.

Questions remain over booster jabs ahead of the winter

2. Could booster jabs help bridge the unvaccinated gap?

Those who are already fully vaccinated but who have weakened immune systems may end up getting a third jab this autumn, according to the advice from the Joint Committee on Vaccine and Immunisation.

The experts have suggested another jab for those over-50s and other vulnerable individuals, as vaccine efficacy will start to fade.

At the moment, 500,000 people with severely compromised immune systems – aged 12 and upwards – are expected to be offered a third dose in a bid to improve protection, but this is not considered a booster jab. The JCVI maintain it is actually just part of the primary vaccination schedule for the most vulnerable in the UK.

Booster jabs – a third dose for those with healthy immune systems – are still under discussion with the JCVI, as more data is needed before a decision is made. The interim advice is to start giving out a third dose to more than 30 million people.

Most Related Links :
todayuknews Governmental News Finance News

Source link

Back to top button
Native News Post